Dynavax Technologies Corp (DVAX)
11.42
-0.34
(-2.89%)
USD |
NASDAQ |
Apr 24, 16:00
11.42
0.00 (0.00%)
After-Hours: 20:00
Dynavax Technologies Total Assets (Quarterly): 997.10M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 997.10M |
| September 30, 2023 | 972.93M |
| June 30, 2023 | 936.43M |
| March 31, 2023 | 969.92M |
| December 31, 2022 | 985.85M |
| September 30, 2022 | 999.34M |
| June 30, 2022 | 1.023B |
| March 31, 2022 | 1.009B |
| December 31, 2021 | 1.039B |
| September 30, 2021 | 919.71M |
| June 30, 2021 | 647.91M |
| March 31, 2021 | 490.12M |
| December 31, 2020 | 353.27M |
| September 30, 2020 | 353.40M |
| June 30, 2020 | 329.31M |
| March 31, 2020 | 259.26M |
| December 31, 2019 | 279.07M |
| September 30, 2019 | 301.02M |
| June 30, 2019 | 267.08M |
| March 31, 2019 | 296.60M |
| December 31, 2018 | 210.88M |
| September 30, 2018 | 236.39M |
| June 30, 2018 | 263.86M |
| March 31, 2018 | 295.33M |
| December 31, 2017 | 218.78M |
| Date | Value |
|---|---|
| September 30, 2017 | 217.83M |
| June 30, 2017 | 151.97M |
| March 31, 2017 | 110.13M |
| December 31, 2016 | 109.68M |
| September 30, 2016 | 139.30M |
| June 30, 2016 | 167.61M |
| March 31, 2016 | 189.64M |
| December 31, 2015 | 216.63M |
| September 30, 2015 | 238.91M |
| June 30, 2015 | 109.49M |
| March 31, 2015 | 112.17M |
| December 31, 2014 | 138.29M |
| September 30, 2014 | 146.90M |
| June 30, 2014 | 173.46M |
| March 31, 2014 | 193.58M |
| December 31, 2013 | 204.62M |
| September 30, 2013 | 91.70M |
| June 30, 2013 | 104.01M |
| March 31, 2013 | 119.62M |
| December 31, 2012 | 139.75M |
| September 30, 2012 | 164.82M |
| June 30, 2012 | 175.90M |
| March 31, 2012 | 120.68M |
| December 31, 2011 | 134.10M |
| September 30, 2011 | 64.72M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
259.26M
Minimum
Mar 2020
1.039B
Maximum
Dec 2021
691.21M
Average
919.71M
Median
Sep 2021
Total Assets (Quarterly) Benchmarks
| Supernus Pharmaceuticals Inc | 1.278B |
| Ligand Pharmaceuticals Inc | 787.22M |
| Pacira BioSciences Inc | 1.574B |
| Esperion Therapeutics Inc | 205.80M |
| PetIQ Inc | 868.23M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 375.02M |
| Shareholders Equity (Quarterly) | 622.07M |
| Debt to Equity Ratio | 0.358 |
| Current Ratio | 13.81 |
| Net Debt Paydown Yield | -0.02% |